MARILYN JALAL: Open Payments
NPI 1932850195 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 34 payments from 14 companies in 2025. Trend: 2023 $352 · 2024 $1,050 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 7 | $127 |
| Lundbeck LLC | 4 | $101 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| ABBVIE INC. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Neos Therapeutics, LP | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: Azstarys, REXULTI, VRAYLAR, Qelbree, INGREZZA, TRINTELLIX, SPRAVATO, COBENFY.
Industry payments across TX — which companies pay providers there.
